Clinical trials: sponsored by RemeGen Co., Ltd.
Healthy
A Single Dose Study to Investigate the Pharmacokinetics (PK) of Telitacicept Pre-filled Injection and Freeze-dried Powder Injection in Chinese Healthy Subjects
This is an open-label, randomized, parallel group, single dose study in healthy Chinese subjects. The purpose of this study is to evaluate the Pharmacokinetics and safety of Telitacicept Pre-filled Injection and Freeze-dried…
- Trial name
- NCT06549959
- Testing
- Telitacicept Pre-filled Injection 80mg, Telitacicept Freeze-dried powder Injection 80mg
- Where
- 3 sites in China
- Volunteers
- 248 people, healthy volunteers welcome
- Sponsor
- RemeGen Co., Ltd.
Healthy
A Phase I Study of TACI-antibody Fusion Protein Injection (RC18) in Healthy Adult Chinese Subjects
to evaluate the pharmacokinetics, and pharmacodynamics of a single dose of Tai Ai injection in healthy adult Chinese subjects
- Trial name
- NCT04235933
- Testing
- Tai Ai(RC18) 80mg, Tai Ai(RC18) 160mg, RC18 240mg
- Where
- China
- Volunteers
- 36 people, healthy volunteers welcome
- Sponsor
- RemeGen Co., Ltd.